Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chest

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.11-2290PMID 22315262PMCID PMC3278050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extended Dalteparin Prophylaxis for Venous Thromboembolic Events

  2012cited by this paper
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©)

  2009cited by this paper
• Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement.

  2009cited by this paper
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study

  2008cited by this paper
• Educational outreach and collaborative care enhances physician's perceived knowledge about Developmental Coordination Disorder

  2008cited by this paper
• “Two per cent isn’t a lot, but when it comes to death it seems quite a lot anyway”: patients’ perception of risk and willingness to accept risks associated with thrombolytic drug treatment for acute stroke

  2008cited by this paper
• Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.

  2008cited by this paper
• Patient acceptance of a foot pump device used for thromboprophylaxis.

  2007cited by this paper
• Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial

  2007cited by this paper
• A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial

  2007cited by this paper
• Gender Differences in Stroke Care Decision-Making

  2006cited by this paper
• Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement

  2006cited by this paper
• Improving the use of research evidence in guideline development: 16. Evaluation

  2006cited by this paper
• Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study

  2006cited by this paper
• Impact of Adherence, Knowledge, and Quality of Life on Anticoagulation Control

  2005cited by this paper
• Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life*

  2005cited by this paper
• Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study

  2005cited by this paper
• Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.

  2005cited by this paper
• Treatment with vitamin K antagonists: patients'quality of life, valuations and adherence

  2004cited by this paper
• Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin.

  2004cited by this paper
• A Comparison of 3 Valuation Methods for Temporary Health States in Patients Treated with Oral Anticoagulants

  2004cited by this paper
• Treatment of venous thromboembolism with vitamin K antagonists: patients’ health state valuations and treatment preferences

  2004cited by this paper
• Patients' perspectives on taking warfarin: qualitative study in family practice

  2004cited by this paper
• Health and Quality of Life Outcomes

  2004cited by this paper
• Five Steps to Conducting a Systematic Review

  2003cited by this paper
• Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis

  2003cited by this paper
• Decisional attributes of patients with diabetes: the aspirin choice.

  2003cited by this paper
• The patient's perspective

  2003cited by this paper
• THE EFFECT OF STABILITY OF ORAL ANTICOAGULANT THERAPY UPON PATIENT‐PERCEIVED HEALTH STATUS AND QUALITY OF LIFE

  2003cited by this paper
• Preference and Compliance in Postoperative Thromboembolism Prophylaxis Among Gynecologic Oncology Patients

  2002cited by this paper
• The effect of qualitative vs. quantitative presentation of probability estimates on patient decision‐making: a randomized trial

  2002cited by this paper
• Presenting risks and benefits to patients

  2002cited by this paper
• Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.

  2002cited by this paper
• Differences in treatment preferences between persons who enrol and do not enrol in a clinical trial.

  2001cited by this paper
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.

  2001cited by this paper
• Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.

  2000cited by this paper
• Patient Preference-based Treatment Thresholds and Recommendations

  2000cited by this paper
• The Management of Oral Anticoagulant Therapy: The Patient’s Point of View

  2000cited by this paper
• The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis.

  2000cited by this paper
• Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.

  2000cited by this paper
• A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.

  1999cited by this paper
• Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

  1999cited by this paper
• Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology.

  1998cited by this paper
• Comparison of the Use of a Foot Pump with the Use of Low-Molecular-Weight Heparin for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement. A Prospective, Randomized Trial*

  1998cited by this paper
• Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.

  1998cited by this paper
• Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. Stroke Prevention in Atrial Fibrillation III Study.

  1998cited by this paper
• Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.

  1998cited by this paper
• A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.

  1998cited by this paper
• Determinants of compliance with anticoagulation: A case-control study.

  1997cited by this paper
• Patient Preferences for Thrombolytic Therapy in Acute Myocardial Infarction

  1997cited by this paper
• The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.

  1996cited by this paper
• Warfarin for atrial fibrillation. The patient's perspective.

  1996cited by this paper
• The efficacy of warfarin for the prevention of stroke in nonvalvular atrial fibrillation: Measuring its minimal clinically important difference from the patients' perspective.

  1996cited by this paper
• Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

  1996cited by this paper
• Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.

  1995cited by this paper
• A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis.

  1994cited by this paper
• The Impact of Long-term Warfarin Therapy on Quality of Life: Evidence From a Randomized Trial

  1991cited by this paper
• The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

  1991cited by this paper
• Loss Aversion in Riskless Choice: A Reference-Dependent Model

  1991cited by this paper

• Venous thromboembolism prophylaxis in adults hospitalised for psychiatric illness: an evidence-based clinical practice guideline developed using GRADE.

  2026cites this paper
• All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a systematic review and meta-analysis.

  2025cites this paper
• Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillation

  2025cites this paper
• Patients’ Preferences Regarding Traditional Chinese Medicine for the Treatment of Chronic Obstructive Pulmonary Disease: Protocol for a Mixed Methods Study

  2025cites this paper
• Promoting informed health choices: the long and winding road

  2025cites this paper
• Extended-duration thromboprophylaxis following major abdominopelvic surgery - For everyone or selected cases only?

  2024cites this paper
• Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy.

  2024cites this paper
• Prophylactic Treatment to Prevent Left Ventricular Thrombus after Anterior Myocardial Infarction Treated with Primary Percutaneous Intervention.

  2024cites this paper
• An assessment of evidence to inform best practice for the communication of acute venous thromboembolism diagnosis: a scoping review

  2024cites this paper
• Left Ventricular Thrombus After Myocardial Infarction: Opinions and Equipoise

  2024cites this paper
• Qualitative study of guideline panelists: Innovative surveys provided valuable insights regarding patient values and preferences.

  2023cites this paper
• A Review of the Preventive Strategies for Venous Thromboembolism in Hospitalized Patients

  2023influential citation
• Lack of alignment between orthopaedic surgeon priorities and patient expectations in total joint arthroplasty

  2023cites this paper
• A novel framework for incorporating patient values and preferences in making guideline recommendations: guideline panel surveys.

  2023cites this paper
• Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke

  2023cites this paper
• Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review

  2022cites this paper
• Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study.

  2022cites this paper
• Methods to Summarize Discrete-Choice Experiments in a Systematic Review: A Scoping Review

  2022cites this paper
• Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review

  2022cites this paper
• Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol

  2022cites this paper
• GRADE summary of findings tables Enhanced Understanding of Values and Preferences Evidence.

  2022cites this paper
• Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.

  2022cites this paper
• Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review

  2022influential citation
• Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer

  2022cites this paper
• Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment

  2021cites this paper
• Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review

  2021cites this paper
• VENOUS THROMBOEMBOLISM

  2021cites this paper
• New methods facilitated the process of prioritizing questions and health outcomes in guideline development.

  2021cites this paper
• [GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences: Risk of bias and indirectness].

  2021cites this paper
• A retrospective comparison of Catheter-directed thrombolysis versus pharmacomechanical thrombolysis for treatment of acute lower extremity deep venous thrombosis.

  2021cites this paper
• Patient satisfaction with dabigatrean and warfarin for stroke prevention in atrial fibrillation: Taiwan PASSION study

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)

  2021cites this paper
• GRADE Leitlinien: 20. Untersuchung der Vertrauenswürdigkeit in die Evidenz zur Beurteilung der Wichtigkeit von Endpunkten oder Werten und Präferenzen – Inkonsistenz, unzureichende Präzision und andere Domänen

  2021cites this paper
• Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants

  2020cites this paper
• Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.

  2020cites this paper
• “What will happen in the future?” A personal VTE journey

  2020cites this paper
• Arzt-Patienten-Beziehung in der Neurologie

  2020cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

  2020cites this paper
• Identifying values and preferences around the choice of analgesia for patients with acute trauma pain in emergency and prehospital settings: using group concept mapping methodology

  2020cites this paper
• A European Academy of Neurology guideline on medical management issues in dementia

  2020cites this paper
• Establishing thresholds for important benefits considering the harms of screening interventions

  2020cites this paper
• Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

  2020cites this paper
• The importance of adherence and persistence in the elderly atrial fibrillation patient

  2020cites this paper
• A European Academy of Neurology guideline on medical management issues in dementia

  2020cites this paper
• PPA_A_279621 1911..1922

  2020cites this paper
• TROMBOEMBOLISMO PULMONAR EM PÓS-OPERATÓRIO DE CIRURGIA ORTOPÉDICA

  2020cites this paper
• Comparing Patient Engagement and Patient Advocacy Activities and Measuring Preferred Roles in Medical Decision Making among Cystic Fibrosis Patients, Caregivers, Family Members and Patient Advocates

  2019cites this paper
• Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.

  2019cites this paper
• New Concepts in the Management of Pulmonary Embolus

  2019cites this paper
• Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?

  2019cites this paper
• Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy - A systematic review.

  2019cites this paper
• Strategies for eliciting and synthesizing evidence for guidelines in rare diseases

  2019cites this paper
• Selection Bias, Orthopaedic Style: Knowing What We Don't Know About Aspirin.

  2019cites this paper
• Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT

  2019cites this paper
• [GRADE: Evidence to Decision (EtD) frameworks - a systematic and transparent approach to making well informed healthcare choices. 2: Clinical guidelines].

  2019cites this paper
• Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia

  2019cites this paper
• Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.

  2019cites this paper
• Patients’ and Caregivers’ Conceptualisations of Pressure Ulcers and the Process of Decision-Making in the Context of Home Care

  2019cites this paper
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline

  2019cites this paper
• Unravelling the mystery of the ‘minimum important difference’ using practical outcome measures in chronic respiratory disease

  2019cites this paper
• Are Older Adults Willing to Consider New Strategies to Reduce Stroke Risk?

  2019cites this paper
• Impacto de Protocolo de Profilaxia para Tromboembolismo Venoso na Qualidade das Prescrições Médicas

  2019cites this paper
• A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions.

  2019cites this paper
• An evolutionary concept analysis of "patients' values".

  2019cites this paper
• Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia

  2019cites this paper
• Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: Update and Periprocedural Management.

  2019cites this paper
• Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review.

  2019cites this paper
• Defining certainty of net benefit: a GRADE concept paper

  2019cites this paper
• Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument.

  2018cites this paper
• Betrixaban (Bevyxxa): A Direct-Acting Oral Anticoagulant Factor Xa Inhibitor.

  2018cites this paper
• Patient perceptions of atrial fibrillation, stroke risk, and oral anticoagulation treatment:

  2018cites this paper
• Evidence-Based Medicine and Bioethics: Implications for Health Care Organizations, Clinicians, and Patients

  2018cites this paper
• The role of extended/outpatient venous thromboembolism prophylaxis after abdominal surgery for cancer or inflammatory bowel disease

  2018cites this paper
• Prevention of Venous Thromboembolism

  2018cites this paper
• Patients' Satisfaction with Anticoagulant Treatment for Venous Thromboembolism

  2018cites this paper
• A systematic review of how patients value COPD outcomes

  2018cites this paper
• Practical Considerations for Using Online Methods to Engage Patients in Guideline Development

  2018cites this paper
• Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey

  2018cites this paper
• The threshold model revisited

  2018cites this paper
• Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase

  2018cites this paper
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline

  2018cites this paper
• Canadian Urological Association guideline: Perioperative thromboprophylaxis and management of anticoagulation.

  2018cites this paper
• Capsule Commentary on Ashburner et al., Electronic Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation: a Randomized Controlled Trial

  2018cites this paper
• The safety of NOACs in atrial fibrillation patient subgroups: A narrative review

  2018cites this paper
• Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities

  2018cites this paper
• How to Best Convey Information About Intensive/Comfort Care to the Family Members of Premature Infants to Enable Unbiased Perinatal Decisions

  2018cites this paper
• GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness.

  2018cites this paper
• Elite athletes and anticoagulant therapy: an intermittent dosing strategy.

  2018cites this paper
• Elite athletes and anticoagulant therapy: an intermittent dosing strategy

  2018cites this paper
• A Bayesian model that jointly considers comparative effectiveness research and patients' preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations.

  2018cites this paper
• Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial

  2018cites this paper
• General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice Experiment

  2018cites this paper
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

  2018cites this paper
• Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson’s Disease and Parkinsonism

  2018cites this paper
• Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study.

  2017cites this paper
• Availability of patient decision aids for stroke prevention in atrial fibrillation: A systematic review

  2017cites this paper
• The GRADE Working Group clarifies the construct of certainty of evidence.

  2017cites this paper
• Development and use of a content search strategy for retrieving studies on patients' views and preferences

  2017cites this paper
• Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies.

  2017cites this paper
• Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology.

  2017cites this paper